SAGE and Independent Scientific Committee on Drugs launch new journal Drug Science, Policy and Law

August 01, 2013

LA, CA (01 August 2013) - SAGE and the Independent Scientific Committee on Drugs (ICSD) today announced the launch of Drug Science, Policy and Law, an online journal supporting the ICSD's goals of providing accessible information on drugs to the public and professionals.

The ISCD was founded to investigate and review the scientific evidence relating to drugs, free from political concerns. Chaired by Professor David Nutt, Head of Department of Neuropsychopharmacology and Molecular Imaging at Imperial College London, the committee represents leading experts on drug science, legislation and policy. Drug Science, Policy and Law will be peer-reviewed, international in scope and grounded in a rigorous evidence base. It aims to be the definitive source of evidence-based information and comment for academics, scientists, policymakers, frontline workers and the general public on drugs and related issues. Each research article will be accompanied by a blog post, written by the author, supporting the Committee's goals of making jargon-free and easy to read content available to a general reader.

"Drug policy continues to be a hotly debated topic amongst policy makers, the public and the media: there is a strong need for unbiased, easy to understand information in this area," said Karen Phillips, Editorial Director, SAGE. "The approach the ICSD is taking with their organization and this new publishing venture fits strongly with SAGE's vision that access to research creates healthy minds and healthy cultures. We see this journal as a major focal point for the international community researching on, or with an interest in, drug policy."

The first article in the journal focuses on a review of khat harm, arguing that the UK government's recent classification decisions was unjustified. Further articles will launch on a monthly basis, with the lay summary available as a blog post on the ICSD website.

"Through our flagship journal Drug Science, Policy and Law, knowledge and analysis will be exchanged not only between academics but also with professionals, policymakers and public" said founding editor Professor David Nutt. "By contributing to the development of consensus across these groups on what is known, what we have yet to establish and what will always be debatable, this venture will support ever more fruitful cooperation towards wiser choices, better treatments and effectual policy. We are delighted to be partnering SAGE in this endeavour, they are a publisher whose vision is aligned with ours."
-end-
For further information about the ICSD's work, follow on Twitter at @ProfDavidNutt or Facebook at http://www.facebook.com/professordavidnutt.

SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC. http://www.sagepublications.com

Drug Science, Policy and Law (DSP) aims to be the definitive source of evidence-based information and comment for academics, scientists, policymakers, frontline workers and the general public on drugs and related issues.

A peer-reviewed journal of science, policy and law relating to drugs, it is international in scope and grounded in a rigorous evidence base making it essential reading for all those in the field and of interest to the general public due to the jargon-free, easy to read style.

Independent Scientific Committee on Drugs (ICSD) is the leading independent scientific body on the harms and benefits of both legal and controlled drugs in the UK. Our eminent drug scientists work together to ensure that the public can access clear, evidence based information on drugs without interference from political or commercial interest. http://www.drugscience.org.uk/homepage.html

SAGE

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.